Skip to main content
. 2018 Jul 16;9:1646. doi: 10.3389/fimmu.2018.01646

Figure 2.

Figure 2

Number of patients and samples tested for anti-ADAMTS13 IgG subclass distribution according to disease stage. The number of common patients between disease stage groups are shown in the small boxes over the connecting lines.